Anti-influenza and anti-COVID-19 drugs promote bacterial antibiotic cross-resistance through drug-specific adaptive pathways.
The extensive use of antiviral drugs for COVID-19 and influenza has increased their release into clinical and environmental settings, yet their potential to promote bacterial antibiotic cross-resistance remains poorly understood. Here, we investigated the antibacterial off-target effects of four clinically used anti-IF...